# Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

> **NCT00108134** · PHASE2 · COMPLETED · sponsor: **Peplin** · enrollment: 60 (—)

## Conditions studied

- Basal Cell Carcinoma

## Interventions

- **DRUG:** PEP005

## Key facts

- **NCT ID:** NCT00108134
- **Lead sponsor:** Peplin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 60 (—)
- **Last updated:** 2008-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00108134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00108134, "Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00108134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*